$13.73
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Syndax Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:SNDX | Benzinga
Syndax Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-1.130
Quarterly Revenue Estimate
$11.10M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$23.68M
Analyze the earnings history of Syndax Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals | -$0.85 | -$1.13 | — | — | $0.00 | $11.10M | — | — | 05/07/2025 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$1.00 | -$1.08 | -$1.10 | -1.85% | $0.00 | $22.23M | $7.68M | -65.45% | 03/03/2025 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.73 | -$1.11 | -$0.98 | 11.71% | $0.00 | $11.20M | $12.50M | 11.61% | 11/05/2024 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.64 | -$0.91 | -$0.80 | 12.09% | $0.00 | — | $3.50M | — | 08/01/2024 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.59 | -$0.98 | -$0.85 | 13.27% | $0.00 | — | $0.00 | — | 05/08/2024 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.62 | -$0.99 | -$1.00 | -1.01% | $0.00 | — | $0.00 | — | 02/27/2024 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.58 | -$0.78 | -$0.73 | 6.41% | $0.00 | — | $0.00 | — | 11/02/2023 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.62 | -$0.73 | -$0.64 | 12.33% | $0.00 | — | $0.00 | — | 08/03/2023 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.63 | -$0.60 | -$0.59 | 1.67% | $0.00 | $430.00K | $0.00 | -100.00% | 05/08/2023 | Get Alert |
| SNDX | Syndax Pharmaceuticals | $1.81 | -$0.65 | -$0.62 | 4.62% | $126.58M | $370.00K | $0.00 | -100.00% | 02/28/2023 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.40 | -$0.63 | -$0.58 | 7.94% | $12.38M | $750.00K | $0.00 | -100.00% | 11/03/2022 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.44 | -$0.67 | -$0.62 | 7.46% | $379.00K | $1.37M | $0.00 | -100.00% | 08/08/2022 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.54 | -$0.63 | -$0.63 | 0.00% | $379.00K | $2.13M | $0.00 | -100.00% | 05/09/2022 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.44 | $0.28 | $1.81 | 546.43% | $380.00K | $58.68M | $126.58M | 115.71% | 03/01/2022 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.46 | -$0.23 | -$0.40 | -73.91% | $379.00K | $29.35M | $12.38M | -57.84% | 11/15/2021 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.42 | -$0.71 | -$0.44 | 38.03% | $379.00K | $220.00K | $379.00K | 72.27% | 08/09/2021 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.56 | -$0.65 | -$0.54 | 16.92% | $379.00K | $220.00K | $379.00K | 72.27% | 05/11/2021 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.44 | -$0.49 | -$0.44 | 10.20% | $380.00K | $200.00K | $380.00K | 90.00% | 03/08/2021 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.41 | -$0.10 | -$0.46 | -360.00% | $379.00K | $16.04M | $379.00K | -97.64% | 11/02/2020 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.47 | -$0.45 | -$0.42 | 6.67% | $379.00K | $400.00K | $379.00K | -5.25% | 08/06/2020 | Get Alert |
| SNDX | Syndax Pharmaceuticals | -$0.53 | -$0.51 | -$0.56 | -9.80% | $379.00K | $840.00K | $379.00K | -54.88% | 05/07/2020 | Get Alert |
Syndax Pharmaceuticals (SNDX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-1.10 | $-1.08 | -1.85 % |
| Q3 | 2024-11-05 | $-0.98 | $-1.11 | 11.7 % |
| Q2 | 2024-08-01 | $-0.80 | $-0.91 | 12.1 % |
| Q1 | 2024-05-08 | $-0.85 | $-0.98 | 13.3 % |
Syndax Pharmaceuticals (SNDX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $7.68M | $22.23M | -65.5 % |
| Q3 | 2024-11-05 | $12.50M | $11.20M | 11.6 % |
| Q1 | 2023-05-08 | $0 | $430.00K | -100.0 % |
| Q4 | 2023-02-28 | $0 | $370.00K | -100.0 % |
FAQ
When is Syndax Pharmaceuticals (NASDAQ:SNDX) reporting earnings?
Syndax Pharmaceuticals (SNDX) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Syndax Pharmaceuticals (NASDAQ:SNDX)?
The Actual EPS was $-1.10, which missed the estimate of $-1.08.
What were Syndax Pharmaceuticals’s (NASDAQ:SNDX) revenues?
The Actual Revenue was $7.7M, which missed the estimate of $22.2M.
Browse earnings estimates, EPS, and revenue on all stocks.